EE402 Cost-Effectiveness Analysis of Pasireotide Long-Acting Release As a Second Line Treatment for Adult Acromegaly Patients
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.703
https://www.valueinhealthjournal.com/article/S1098-3015(23)00803-3/fulltext
Title :
EE402 Cost-Effectiveness Analysis of Pasireotide Long-Acting Release As a Second Line Treatment for Adult Acromegaly Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00803-3&doi=10.1016/j.jval.2023.03.703
First page :
Section Title :
Open access? :
No
Section Order :
10182